These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 18054347

  • 21. Pharmacokinetic and pharmacodynamic study on amrubicin and amrubicinol in Japanese patients with lung cancer.
    Makino Y, Yamamoto N, Sato H, Ando R, Goto Y, Tanai C, Asahina H, Nokihara H, Sekine I, Kunitoh H, Ohe Y, Sugiyama E, Yokote N, Tamura T, Yamamoto H.
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):861-9. PubMed ID: 22042514
    [Abstract] [Full Text] [Related]

  • 22. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
    Iwaki K, Sakaeda T, Kakumoto M, Nakamura T, Komoto C, Okamura N, Nishiguchi K, Shiraki T, Horinouchi M, Okumura K.
    J Pharm Pharmacol; 2006 Dec; 58(12):1617-22. PubMed ID: 17331325
    [Abstract] [Full Text] [Related]

  • 23. Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line.
    Decorti G, Peloso I, Favarin D, Klugmann FB, Candussio L, Crivellato E, Mallardi F, Baldini L.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):525-30. PubMed ID: 9655898
    [Abstract] [Full Text] [Related]

  • 24. Role of xenobiotic efflux transporters in resistance to vincristine.
    Huang RS, Murry DJ, Foster DR.
    Biomed Pharmacother; 2008 Feb; 62(2):59-64. PubMed ID: 17583464
    [Abstract] [Full Text] [Related]

  • 25. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells.
    Han LY, Ye MZ, Li YP, Wang BW, Wang Q, Zhao SH, Li HL.
    Chin Med J (Engl); 2008 May 05; 121(9):800-5. PubMed ID: 18701045
    [Abstract] [Full Text] [Related]

  • 26. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
    Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B.
    Pharmazie; 2008 Jul 05; 63(7):528-33. PubMed ID: 18717489
    [Abstract] [Full Text] [Related]

  • 27. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN, Lau NS, Chang KM, Leong CF, Zakaria Z.
    Singapore Med J; 2007 Oct 05; 48(10):932-8. PubMed ID: 17909680
    [Abstract] [Full Text] [Related]

  • 28. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells.
    Dupuy J, Alvinerie M, Ménez C, Lespine A.
    Chem Biol Interact; 2010 Aug 05; 186(3):280-6. PubMed ID: 20513441
    [Abstract] [Full Text] [Related]

  • 29. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients.
    Matsunaga Y, Hamada A, Okamoto I, Sasaki J, Moriyama E, Kishi H, Matsumoto M, Hira A, Watanabe H, Saito H.
    Ther Drug Monit; 2006 Feb 21; 28(1):76-82. PubMed ID: 16418698
    [Abstract] [Full Text] [Related]

  • 31. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein.
    Ji Y, Morris ME.
    Biochem Pharmacol; 2005 Aug 15; 70(4):640-7. PubMed ID: 16002050
    [Abstract] [Full Text] [Related]

  • 32. Uptake and intracellular distribution of amrubicin, a novel 9-amino-anthracycline, and its active metabolite amrubicinol in P388 murine leukemia cells.
    Yamaoka T, Hanada M, Ichii S, Morisada S, Noguchi T, Yanagi Y.
    Jpn J Cancer Res; 1999 Jun 15; 90(6):685-90. PubMed ID: 10429662
    [Abstract] [Full Text] [Related]

  • 33. In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein.
    Pichler A, Zelcer N, Prior JL, Kuil AJ, Piwnica-Worms D.
    Clin Cancer Res; 2005 Jun 15; 11(12):4487-94. PubMed ID: 15958634
    [Abstract] [Full Text] [Related]

  • 34. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
    Zhang C, Kwan P, Zuo Z, Baum L.
    Life Sci; 2010 Jun 05; 86(23-24):899-905. PubMed ID: 20417647
    [Abstract] [Full Text] [Related]

  • 35. Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.
    Leung S, Bendayan R.
    Can J Physiol Pharmacol; 1999 Aug 05; 77(8):625-30. PubMed ID: 10543726
    [Abstract] [Full Text] [Related]

  • 36. Cytokine-induced killer cells showing multidrug resistance and remaining cytotoxic activity to tumor cells after transfected with mdr1 cDNA.
    Li HF, Yang YH, Shi YJ, Wang YQ, Zhu P.
    Chin Med J (Engl); 2004 Sep 05; 117(9):1348-52. PubMed ID: 15377427
    [Abstract] [Full Text] [Related]

  • 37. [Pharmacokinetic study of amrubicin in a case of small lung cancer on hemodialysis].
    Ohsawa M, Demizu M, Chihara S, Ueda H, Igarashi T, Tomiyama N, Nakashima Y, Hosoi K, Min K.
    Gan To Kagaku Ryoho; 2009 Aug 05; 36(8):1311-4. PubMed ID: 19692770
    [Abstract] [Full Text] [Related]

  • 38. Resistance to purine and pyrimidine nucleoside and nucleobase analogs by the human MDR1 transfected murine leukemia cell line L1210/VMDRC.06.
    Zeng H, Lin ZP, Sartorelli AC.
    Biochem Pharmacol; 2004 Sep 01; 68(5):911-21. PubMed ID: 15294454
    [Abstract] [Full Text] [Related]

  • 39. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 40. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport.
    Barthomeuf C, Demeule M, Grassi J, Saidkhodjaev A, Beliveau R.
    Planta Med; 2006 Jun 01; 72(7):634-9. PubMed ID: 16739070
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.